Published in Ann Intern Med on February 01, 1992
Colony-stimulating factors for febrile neutropenia during cancer therapy. N Engl J Med (2013) 4.20
Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis. Eur J Clin Microbiol Infect Dis (1994) 0.77
GM-CSF in Hodgkin disease. Ann Intern Med (1992) 0.75
Valuing clinical strategies early in their development. Ann Intern Med (1992) 0.75
GM-CSF in Hodgkin disease. Ann Intern Med (1992) 0.75
Granulocyte-macrophage colony-stimulating factor (GM-CSF): answers or more questions? Ann Intern Med (1992) 0.75
Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA (1999) 7.94
The uncertainty principle and industry-sponsored research. Lancet (2000) 7.75
Assessing the impact of continuous quality improvement on clinical practice: what it will take to accelerate progress. Milbank Q (1998) 5.63
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38
The learning curve for laparoscopic cholecystectomy. The Southern Surgeons Club. Am J Surg (1995) 3.32
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant (2007) 2.74
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med (2000) 2.65
The role of inadequate health literacy skills in colorectal cancer screening. Cancer Invest (2001) 2.54
Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 2.33
Health literacy and shared decision making for prostate cancer patients with low socioeconomic status. Cancer Invest (2001) 2.16
Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology (2003) 1.74
AHI1 mutations cause both retinal dystrophy and renal cystic disease in Joubert syndrome. J Med Genet (2005) 1.58
Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care (2005) 1.56
AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med (1996) 1.54
Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion. Circulation (2000) 1.53
Health literacy and patient knowledge in a Southern US HIV clinic. Int J STD AIDS (2004) 1.52
Variations in intensive care unit utilization for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med (1998) 1.52
The impact of housing status on health care utilization among persons with HIV disease. J Health Care Poor Underserved (1996) 1.50
Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1995) 1.48
Performance measurement in pneumonia care: beyond report cards. Mayo Clin Proc (1998) 1.45
Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant (2007) 1.43
Variations in institutional review board decisions for HIV quality of care studies: a potential source of study bias. J Acquir Immune Defic Syndr (2001) 1.36
IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol (2000) 1.31
Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (2000) 1.30
Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst (2001) 1.26
Comparison of perspectives on prostate cancer: analyses of survey data. Urology (1997) 1.23
Self-perceived unmet health care needs of persons enrolled in HIV care. J Community Health (1996) 1.17
Preventing the social breakdown syndrome. Res Publ Assoc Res Nerv Ment Dis (1969) 1.12
Improving rates of cervical cancer screening and Pap smear follow-up for low-income women with limited health literacy. Cancer Invest (2001) 1.08
Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review. Urology (2001) 1.06
Racial variation in the use of laparoscopic cholecystectomy in the Department of Veterans Affairs medical system. J Am Coll Surg (1999) 1.05
Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Oncologist (2001) 1.04
In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome. Neurogenetics (2006) 1.02
A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med (2000) 0.99
Prostate cancer patients' utilities for health states: how it looks depends on where you stand. Med Decis Making (1998) 0.99
Finland's health care system. Universal access to health care in a capitalistic democracy. JAMA (1994) 0.98
Radiocarbon dating using electrostatic accelerators: negative ions provide the key. Science (1977) 0.97
Predicting in-hospital mortality of patients with AIDS-related Pneumocystis carinii pneumonia: an example of hierarchically optimal classification tree analysis. Stat Med (1997) 0.95
Nosocomial tuberculosis prevention measures among two groups of US hospitals, 1992 to 1996. Chest (2000) 0.95
A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4) localizes to a 500-kb interval on chromosome 9q34. Neurogenetics (2000) 0.94
Quality of life and health service use among HIV-infected patients with chronic diarrhea. J Acquir Immune Defic Syndr (1993) 0.93
Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J Acquir Immune Defic Syndr (1993) 0.92
Demonstration of presbycusis across repeated measures in a nonhuman primate species. Behav Neurosci (1983) 0.90
Thrombotic thrombocytopenic purpura after stenting and ticlopidine. Lancet (1998) 0.90
Diffusion of laparoscopic cholecystectomy in the Veterans Affairs health care system, 1991-1995. Eff Clin Pract (1999) 0.90
Discovery of a new gravitational lens system. Science (1984) 0.89
HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J Gen Intern Med (2001) 0.89
Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know? Bone Marrow Transplant (1998) 0.86
A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK. Ann Oncol (2002) 0.86
Health care in Hong Kong and mainland China: one country, two systems? Health Policy (2000) 0.84
Geographic variation in the management and outcome of patients with AIDS-related Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.84
Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer. Cancer Res (1987) 0.84
The effect of ethnicity on ICU use and DNR orders in hospitalized AIDS patients. J Clin Ethics (1997) 0.83
Improved outcomes in intensive care units for AIDS-related Pneumocystis carinii pneumonia: 1987-1991. J Acquir Immune Defic Syndr (1993) 0.83
Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy. Blood Rev (2002) 0.83
Treating malignant pleural effusions cost consciously. Chest (1998) 0.83
Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs. Urology (1997) 0.82
Predictors of resource utilization for hospitalized patients with Pneumocystis carinii pneumonia (PCP): a summary of effects from the multi-city study of quality of PCP care. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.82
Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists. Gynecol Oncol (1998) 0.81
Spouse ratings of quality of life in patients with metastatic prostate cancer of lower socioeconomic status: an assessment of feasibility, reliability, and validity. Urology (2001) 0.81
Ticlopidine and TTP after coronary stenting. JAMA (1999) 0.81
Canine arterial calcium transport during endotoxin shock. Circ Shock (1980) 0.81
Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine. Cancer Treat Rep (1986) 0.81
Does experience improve hospital performance in treating patients with AIDS? Health Policy (1993) 0.80
Informal caregivers of persons with AIDS. J Palliat Care (1995) 0.80
Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer. Urology (1995) 0.80
Locally advanced head and neck cancer. Curr Treat Options Oncol (2001) 0.79
Gender differences in care for acquired immunodeficiency syndrome-related Pneumocystis carinii pneumonia. Womens Health Issues (1998) 0.79
Variations in medical care for HIV-related Pneumocystis carinii pneumonia: a comparison of process and outcome at two hospitals. Chest (1997) 0.79
A multi-attribute model of prostate cancer patient's preferences for health states. Qual Life Res (1999) 0.79
Evaluation and appraisal of randomized controlled trials in myeloma. Ann Oncol (2001) 0.79
Autologous bone marrow transplantation. Curr Probl Cancer (1991) 0.79
Changes in gingiva and gingival flora with bonding and banding. Angle Orthod (1987) 0.78
A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program. Cancer Causes Control (1996) 0.77
Identifying providers of care to individuals with human immunodeficiency virus for a mail survey using a prescription tracking database. J Clin Epidemiol (1999) 0.77
Staging and therapy of orbital lymphomas. Cancer (1986) 0.77
Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol (1998) 0.77
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplant (2016) 0.77
Performance measurement in prostate cancer care: beyond report cards. Urology (1996) 0.76
Frequencies of variants of candidate genes in different age groups of hypertensives. Clin Exp Pharmacol Physiol (1994) 0.76
Economic analyses of new technologies: the case of stem-cell transplantation. J Clin Oncol (1997) 0.75
Quality improvement: carrots or sticks? J Clin Oncol (1999) 0.75
Gender differences in early suspicion of tuberculosis in hospitalized, high-risk patients during 4 epidemic years, 1987 to 1990. Infect Control Hosp Epidemiol (1997) 0.75
Pricing, profits and pharmacoeconomics--for whose benefit? Expert Opin Pharmacother (2001) 0.75
Multi-city study of quality of care for HIV-related Pneumocystis carinii pneumonia: successfully collecting highly sensitive information. Clin Perform Qual Health Care (1995) 0.75
Itraconazole plasma and tissue concentrations in the spiny lizard (Sceloporus sp.) following once-daily dosing. J Zoo Wildl Med (1997) 0.75
QOL and outcomes research in prostate cancer patients with low socioeconomic status. Oncology (Williston Park) (1999) 0.75
A review of the costs, cost-effectiveness and third-party charges of bone marrow transplantation. Stem Cells (1996) 0.75
Does reimbursement affect physician decision making? Cancer Treat Res (2000) 0.75
Hepatic dysfunction in a population of antibody-deficient patients: prevalence, aetiology and outcome of PCR screening for hepatitis C and G viruses. Vox Sang (1999) 0.75
Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia. Pharmacoeconomics (1996) 0.75
Pharmacoeconomics of amifostine in ovarian cancer. Semin Oncol (1999) 0.75
Growth of oncology physician practice management companies. Cancer Invest (1999) 0.75
Assessing the quality of clinical trials: can it be done? Curr Oncol Rep (2001) 0.75
Variations in inpatient care for HIV-related tuberculosis patients during a recent nosocomial outbreak of multidrug-resistant tuberculosis. J Acquir Immune Defic Syndr (1999) 0.75
The Dutchess County project. Milbank Mem Fund Q (1966) 0.75
Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients. Cancer Invest (1999) 0.75
The scarlet eye colour gene of the tephritid fruit fly: Bactrocera tryoni and the nature of two eye colour mutations. Insect Mol Biol (2003) 0.75
Health economics in the treatment of colorectal cancer. Cancer Invest (1998) 0.75